Checkpoint Therapeutics Inc (NASDAQ:CKPT)

1.81
Delayed Data
As of Jan 17
 -0.02 / -1.09%
Today’s Change
1.12
Today|||52-Week Range
5.20
+5.23%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 15.00, with a high estimate of 20.00 and a low estimate of 8.00. The median estimate represents a +728.73% increase from the last price of 1.81.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$400.0K
Reporting Date
Mar 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.11%
 
 
 
 
 
 
Growthannually 48.82%
 
 
 
 
 

Sales

Growthquarterly 42.86%
 
 
 
 
 
 
Growthannually -40.26%
 
 
 
 
 
Key to the earnings and sales forecast charts.